OUR R&D APROACH TO COVID-19
As the maritime and aviation industries progress new strategies to manage Covid-19, our Research & Development (R&D) team has been enhancing our Aiber product, supporting clients to make current and future air travel and freight transport safer as they adapt to the new environment.
Our new R&D involves assessing possible risks and supporting cabin crew and seafarers to follow the latest containment protocols inflight and at sea. Our innovation is applicable to any communicable disease, not just Covid-19.
MIME® Human Factors Trials - RBS Six Nations Rugby Championship & Edinburgh Marathon Festival.
Before taking our product to market, the Digital Health & Care Institute for Scotland (DHI) funded essential Research & Development (R&D) and it was completed with support from the British Red Cross, a UK Ambulance Service and University of Aberdeen.
The purpose was to explore how technology is used in real life first response situations. During this project the team learned about the usefulness and usability of digital technologies in a first responder context and what matters on-scene.
In particular the team focused on the actions that end users "do" or "didn't do" and explored the interactions between the first responders and the technology interface. This R&D trial took place during large outdoor events in the city of Edinburgh.
The outcome of the Human Factors trials provided an opportunity for relevant adjustments to the product user interface. Useful outcome measures also included the connections between the software and clinical grade medical sensors, the interface display and usefulness of reporting capacity.